Picture of Sensorion SA logo

ALSEN — Sensorion SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Sensorion, Cochlear To Begin First Clinical Trial Of SENS-401

Sept 8 (Reuters) - SENSORION SA  ALSEN.PA :
    * SENSORION AND COCHLEAR TO BEGIN FIRST CLINICAL TRIAL OF
SENS-401
FOR HEARING PRESERVATION IN COMBINATION WITH COCHLEAR
IMPLANTATION
    * STUDY WILL AIM TO MEASURE PERILYMPH PK OF SENS401 AND TO
EXPLORE
THERAPEUTIC EFFECT OF SENS-401 ON EARLY HEARING OUTCOMES UPON
COCHLEAR IMPLANTATION
    * TRIAL WILL BE FULLY FUNDED UNDER EXISTING AGREEMENT
BETWEEN
COCHLEAR AND SENSORION

Source text for Eikon:  ID:nBw7gRkdFa 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))

Recent news on Sensorion SA

See all news